Chronic Pulmonary Aspergillosis: An Update on Diagnosis and Treatment | Zendy

C. Godet | Zendy; Bruno Philippe | Zendy; François Laurent | Zendy; J. Cadranel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Chronic Pulmonary Aspergillosis: An Update on Diagnosis and Treatment

Author(s) -

C. Godet,

Bruno Philippe,

François Laurent,

J. Cadranel

Publication year - 2014

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000362674

Subject(s) - medicine , aspergilloma , allergic bronchopulmonary aspergillosis , aspergillosis , intensive care medicine , antifungal , pulmonary aspergillosis , mycosis , disease , radiological weapon , aspergillus fumigatus , dermatology , surgery , pathology , immunology , immunoglobulin e , antibody

Chronic pulmonary aspergillosis (CPA) affects individuals with non-systemic or mildly systemic immunodepression or altered pulmonary integrity due to underlying disease. It has been reported with a variety of clinical and radiological patterns. The condition should be distinguished from simple aspergilloma and allergic bronchopulmonary aspergillosis as well as invasive aspergillosis in severely immunocompromised patients. CPA generally requires long-term antifungal treatment and surgery may be considered. Life-threatening haemoptysis may be prevented by bronchial arteriography with embolisation. However, currently there are no documented treatment recommendations for CPA. This review provides an up-to-date practical overview of this condition, including a comprehensive update on diagnosis and management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research